首页> 外文期刊>The Journal of Nutrition: Official Organ of the American Institute of Nutrition >Select 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Vary in Their Ability to Reduce Egg Yolk Cholesterol Levels in Laying Hens through Alteration of Hepatic Cholesterol Biosynthesis and Plasma VLDL Composition
【24h】

Select 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Vary in Their Ability to Reduce Egg Yolk Cholesterol Levels in Laying Hens through Alteration of Hepatic Cholesterol Biosynthesis and Plasma VLDL Composition

机译:选择3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂通过改变肝脏胆固醇的生物合成和血浆VLDL组成降低蛋鸡胆固醇蛋黄胆固醇的能力而变化

获取原文
           

摘要

The inability to markedly attenuate cholesterol levels in chicken eggs has led to speculation that cholesterol is essential for yolk formation and that egg production would cease when yolk cholesterol deposition was inadequate for embryonic survival. However, this critical level hypothesis remains unproven. Here, we determine the relative responsiveness of laying hens to three select inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR), the rate-limiting enzyme of cholesterol biosynthesis. A control diet, either alone or supplemented with one of two dietary levels (0.03 or 0.06%) of atorvastatin, lovastatin, or simvastatin, was fed to White Leghorn hens for 5 wk. Liver cholesterol concentrations (mg/g tissue) were decreased (P ≤ 0.05) by each HMGR inhibitor; however, total liver cholesterol (mg) did not differ among treatments. Microsomal hepatic HMGR activities were increased one- to twofold in all HMGR inhibitor-treated groups, while HMGR mRNA levels were unaffected. Diameters of plasma VLDL particles, the main cholesterol-carrying yolk precursor macromolecules, were reduced (P ≤ 0.05) only in hens fed 0.06% atorvastatin, and the particles contained 38% less total cholesterol (P ≤ 0.05) than controls. Plasma total cholesterol concentrations were lowered (P ≤ 0.05) by both doses of atorvastatin (?56, ?63%) and simvastatin (?36,?45%). Egg cholesterol contents were maximally reduced by 46% (P ≤ 0.05), 7% (P 0.05), and 22% (P ≤ 0.05) in hens fed the 0.06% level of atorvastatin, lovastatin, and simvastatin, respectively, while overall egg production [?19% (P ≤ 0.05), +4% (P 0.05), and -3% (P 0.05)], was much less affected. We concluded that cholesterol per se may not be an obligatory component for yolk formation in chickens and, as such, may be amenable to further pharmacological manipulation
机译:无法显着降低鸡蛋中胆固醇的水平导致人们推测胆固醇对于蛋黄的形成至关重要,如果蛋黄胆固醇的沉积不足以维持胚胎存活,鸡蛋的生产就会停止。但是,这一临界水平的假设仍未得到证实。在这里,我们确定蛋鸡对三种选择的3-羟基-3-甲基戊二酰辅酶A还原酶(HMGR)(胆固醇生物合成的限速酶)的相对响应性。对照饮食,单独或补充两种饮食水平的阿托伐他汀,洛伐他汀或辛伐他汀之一(0.03或0.06%)之一,喂给白来亨鸡,饲养5周。每种HMGR抑制剂可降低肝胆固醇浓度(mg / g组织)(P≤0.05);但是,不同治疗之间的总肝胆固醇(mg)没有差异。在所有HMGR抑制剂治疗组中,微粒体肝HMGR活性增加了1-2倍,而HMGR mRNA水平未受影响。仅饲喂0.06%阿托伐他汀的母鸡血浆VLDL颗粒(主要的胆固醇蛋黄前体大分子)的直径降低(P≤0.05),且颗粒中的总胆固醇比对照组少38%(P≤0.05)。两种剂量的阿托伐他汀(?56,?63%)和辛伐他汀(?36,?45%)均降低血浆总胆固醇浓度(P≤0.05)。饲喂0.06%阿托伐他汀,洛伐他汀和辛伐他汀的母鸡的鸡蛋胆固醇含量最高分别降低了46%(P≤0.05),7%(P> 0.05)和22%(P≤0.05)。产蛋率[?19%(P≤0.05),+ 4%(P> 0.05)和-3%(P> 0.05)]受的影响要小得多。我们得出的结论是,胆固醇本身可能不是鸡卵黄形成的必需成分,因此,可能需要进一步的药理操作

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号